All Stories

  1. Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2019, Taylor & Francis

    Donald Mahler

  2. Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease

    Article • Annals of the American Thoracic Society, May 2017, American Thoracic Society

    Donald Mahler

  3. Greater dyspnea is associated with lower health-related quality of life among European patients with COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2017, Dove Medical Press

    Donald Mahler